0.07786
0.00556 (7.69%)
0.00556 (7.69%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Algernon Pharmaceuticals Inc (QB) | AGNPF | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00556 | 7.69% | 0.07786 | 0.07 | 0.083 | 0.07 | 0.0723 | 16:55:03 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.027 | 0.1328 | 0.1058 | 79.67% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 95 | 586,611 | $ 0.075935 | $ 44,544 | 46,493 | 0.036 - 0.083 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:27:55 | 10,000 | $ 0.07786 | USD |
Algernon Pharmaceuticals (QB) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 5.59M | 71.75M | - | - | 58.63M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 9.29k | $ - | 0.00% | - | - |
Algernon Pharmaceuticals (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGNPF Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.06 | 0.083 | 0.0578 | 0.0680308 | 11,978 | 0.01786 | 29.77% |
| 1 Month | 0.067 | 0.083 | 0.044 | 0.0587958 | 22,667 | 0.01086 | 16.21% |
| 3 Months | 0.04 | 0.083 | 0.036 | 0.0570586 | 37,444 | 0.03786 | 94.65% |
| 6 Months | 0.04 | 0.083 | 0.036 | 0.0570586 | 37,444 | 0.03786 | 94.65% |
| 1 Year | 0.04 | 0.083 | 0.036 | 0.0570586 | 37,444 | 0.03786 | 94.65% |
| 3 Years | 0.04 | 0.083 | 0.036 | 0.0570586 | 37,444 | 0.03786 | 94.65% |
| 5 Years | 0.04 | 0.083 | 0.036 | 0.0570586 | 37,444 | 0.03786 | 94.65% |
Algernon Pharmaceuticals (QB) Description
| The company is a clinical stage pharmaceutical development company focused on the areas of non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD). The company's key compounds were identified using a drug repurposing strategy. |
